Replimune Group Inc (REPL) Stock Price, Quote, News & History

REPLNASDAQ
$9.99
-0.01-0.10%
Last update: Jun 18, 2:41 PM

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-277.91M
Investing Cash Flow (TTM)
216.64M
Financing Cash Flow (TTM)
10.49M
Free Cash Flow (TTM)
-283.27M
Capital Expenditure (TTM)
-5.35M
Net Change in Cash (TTM)
-50.79M

Analyst Trends and Forecast

2
Feb
3
2
Apr
1
Jun
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
2.1
Sell
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$632.94M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
3.92
Earnings Yield % (TTM)
-34.40%
Earnings Yield % (FWD)
-27.10%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$2.55

Company Debt

Total Debt
$47.63M
LT Debt
$47.63M
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-$701.00K
Total Cash
$122.95M
Debt to Equity
0.36
Issuance of Debt (TTM)
-$701.00K
Repayment of Debt (TTM)
-$701.00K

Key Statistics

Open
$10.05
Close
-
Volume / Avg.
1.24M / 7.32M
Day Range
$9.97 - $10.44
52 Wk Range
1.50 - 13.24
Market Cap
$783.65M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
70
Short Interest
61.88%
Days to Cover
2.94

About

Sector
Health Care
Industry
Biotechnology
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a ...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Replimune Group (REPL) stock?

A

You can purchase shares of Replimune Group (NASDAQ:REPL) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Replimune Group (REPL) competitors?

A

There are no as such competitors for Replimune Group.

Q

What is the forecast, or price target, for Replimune Group (REPL) stock?

A

Replimune Group has a consensus price target of $7.86.

Q

What is the current price for Replimune Group (REPL)?

A

The stock price for Replimune Group (NASDAQ: REPL) is $9.99 last updated June 18, 2026 at 2:41 PM EDT.

Q

Does Replimune Group (REPL) pay a dividend?

A

There are no upcoming dividends for Replimune Group.

Q

When is Replimune Group (NASDAQ:REPL) reporting earnings?

A

Replimune Group does not have any upcoming earnings scheduled.

Q

Is Replimune Group (REPL) going to split?

A

There is no upcoming split for Replimune Group.

Q

What sector and industry does Replimune Group (REPL) operate in?

A

Replimune Group is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.